TREATMENT OF ANGIOPOIETIN LIKE 7 (ANGPTL7) RELATED DISEASES

Provided herein are oligonucleotide compositions that inhibit ANGPTL7 and reduce intraocular pressure when administered to an eye. The oligonucleotide compositions contain nucleoside modifications. L'invention concerne des compositions oligonucléotidiques qui inhibent l'ANGPTL7 et réduisen...

Full description

Saved in:
Bibliographic Details
Main Authors GOTTESMAN, OMRI, LEWIS, DAVID, ROZEMA, DAVID, BRUSE, SHANNON, CAJES, BRIAN, BUSKE, PAUL
Format Patent
LanguageEnglish
French
Published 03.12.2020
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:Provided herein are oligonucleotide compositions that inhibit ANGPTL7 and reduce intraocular pressure when administered to an eye. The oligonucleotide compositions contain nucleoside modifications. L'invention concerne des compositions oligonucléotidiques qui inhibent l'ANGPTL7 et réduisent la pression intraoculaire lorsqu'elles sont administrées à un il. Les compositions d'oligonucléotides contiennent des modifications de nucléosides.
Bibliography:Application Number: CA20203140917